A Phase Ib Trial of Neoadjuvant Low-Dose Radiation Therapy, Chemotherapy, and Durvalumab for Potentially Resectable Stage III NSCLC

被引：0
|
作者：
Li, J. [1 ]
机构：
[1] Sichuan Prov Canc Hosp, Chengdu, Peoples R China
来源：
JOURNAL OF THORACIC ONCOLOGY | 2021年 / 16卷 / 10期
关键词：
stage III nonsmall cell lung cancer; neoadjuvant immunotherapy; low dose radiation therapy;
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
P29.07
引用
收藏
页码：S1049 / S1050
页数：2
相关论文
共 50 条
  • [21] Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy (SBRT) for Resectable and Borderline Resectable (BLR) Pancreas Cancer
    Kharofa, J. R., Jr.
    Mierzwa, M. L.
    Olowokure, O.
    Sussman, J.
    Latif, T.
    Gupta, A.
    Esslinger, R.
    McGill, B.
    Wolf, E.
    Ahmad, S.
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2018, 102 (03): : S133 - S133
  • [22] Low-dose radiotherapy as a chemosensitizer of neoadjuvant chemotherapy for LA-NPC: a phase II trial
    Feng, M.
    Yin, Q.
    Qi, Y.
    Li, L.
    Lan, M.
    Lai, X.
    Fan, M.
    Zhang, J.
    Li, F.
    Wang, W.
    Lang, J.
    RADIOTHERAPY AND ONCOLOGY, 2021, 161 : S811 - S812
  • [23] Phase 2 trial of neoadjuvant toripalimab with chemotherapy for resectable stage III non-small-cell lung cancer
    Zhao, Ze-Rui
    Yang, Chao-Pin
    Chen, Si
    Yu, Hui
    Lin, Yong-Bin
    Lin, Yao-Bin
    Qi, Han
    Jin, Jie-Tian
    Lian, Shan-Shan
    Wang, Yi-Zhi
    You, Jin-Qi
    Zhai, Wen-Yu
    Long, Hao
    ONCOIMMUNOLOGY, 2021, 10 (01):
  • [24] Proton-therapy and concurrent chemotherapy in stage III NSCLC: Effects on durvalumab eligibility and safety profile
    Cortiula, F.
    De Ruysscher, D.
    Dursun, S.
    Steens, M.
    Bootsma, G.
    Canters, R.
    Rinaldi, I.
    Taasti, V. T.
    Houben, R.
    Reynders, K.
    Peeters, S.
    Angrisani, A.
    Hattu, D.
    Hendriks, L.
    ANNALS OF ONCOLOGY, 2022, 33 : S85 - S85
  • [25] Pattern of Marginal Local Failure in a Phase II Trial of Neoadjuvant Chemotherapy and Stereotactic Body Radiation Therapy for Resectable and Borderline Resectable Pancreas Cancer
    Kharofa, Jordan
    Mierzwa, Michelle
    Olowokure, Olugbenga
    Sussman, Jeffrey
    Latif, Tahir
    Gupta, Anumeha
    Xie, Changchun
    Patel, Sameer
    Esslinger, Hope
    Mcgill, Brian
    Wolf, Eric
    Ahmad, Syed A.
    AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS, 2019, 42 (03): : 247 - 252
  • [26] The relationship between radiation dose in definitively curative intended chemoradiotherapy followed by durvalumab therapy and the occurrence of pneumonitis in patients with stage III NSCLC
    Matousek, M.
    Schragel, F.
    Resl, C.
    Hackner, K.
    Errhalt, P.
    Georg, P.
    WIENER KLINISCHE WOCHENSCHRIFT, 2023, 135 (19-20) : 574 - 575
  • [27] IMpower030: Phase III Study Evaluating Neoadjuvant Treatment of Resectable Stage II-IIIB NSCLC with Atezolizumab plus Chemotherapy
    Rizvi, N.
    Gandara, D.
    Solomon, B.
    Kim, A.
    Brunelli, A.
    Sun, S.
    Gitlitz, B.
    Tajima, K.
    Lin, W.
    Sandler, A.
    Peters, S.
    JOURNAL OF THORACIC ONCOLOGY, 2018, 13 (10) : S863 - S863
  • [28] SHR-1316 vs placebo in combination with chemotherapy as perioperative treatment in patients with resectable stage II-III NSCLC: A randomized, double-blind, multicenter, phase Ib/III trial
    Wu, Y-L.
    Chen, K.
    Xing, W.
    Chen, Q.
    Liu, L.
    Zhang, Q.
    Ge, D.
    Liu, Y-H.
    Lin, X.
    Wang, L.
    Huang, Y.
    Zhong, W-Z.
    ANNALS OF ONCOLOGY, 2022, 33 : S72 - S72
  • [29] Phase 1 Trial of Total Neoadjuvant Therapy With Short-Course Chemoradiotherapy Followed by Chemotherapy for Patients With Potentially Resectable Gastric Cancer
    Badgwell, Brian
    Ikoma, Naruhiko
    Murphy, Mariela Blum
    Li, Jenny
    Wang, Xuemei
    Minsky, Bruce D.
    Estrella, Jeannelyn
    Mansfield, Paul
    Ajani, Jaffer
    Das, Prajnan
    INTERNATIONAL JOURNAL OF RADIATION ONCOLOGY BIOLOGY PHYSICS, 2025, 121 (02): : 423 - 431
  • [30] Phase I Trial of Short-Course Chemoradiotherapy followed by Chemotherapy as Total Neoadjuvant Therapy for Patients with Potentially Resectable Gastric Cancer
    Badgwell, Brian
    Das, Prajnan
    Ikoma, Naruhiko
    Blum, Mariela
    Li, Jenny
    Estrella, Jeannelyn
    Minsky, Bruce
    Mansfield, Paul F.
    Ajani, Jaffer
    ANNALS OF SURGICAL ONCOLOGY, 2024, 31 (01) : S45 - S45
12345